Literature DB >> 27099924

Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men - an exploratory study.

Véronique Desgagné1,2, Simon-Pierre Guay1,2, Renée Guérin3, François Corbin1, Patrick Couture4, Benoit Lamarche4, Luigi Bouchard1,2.   

Abstract

A high consumption of trans fatty acids (TFAs) is associated with an increased risk of cardiovascular diseases (CVDs). High-density lipoproteins (HDLs) have many cardioprotective properties and transport functional microRNAs (miRNAs) to recipient cells. We hypothesized that dietary TFAs modify the HDL-carried miRNA profile, therefore modulating its cardioprotective properties. We assessed whether consumption of dietary TFAs modifies HDL-carried miR-223-3p and miR-135a-3p concentration and the inter-relationship between diet-induced changes in HDL-carried miRNA concentration and CVD risk markers. In a double blind, randomized, crossover, controlled study, 9 men were fed each of 3 experimental isoenergetic diets: 1) High in industrial TFA (iTFA; 3.7% energy); 2) High in TFA from ruminants (rTFA; 3.7% energy); 3) Low in TFA (control; 0.8% energy) for 4 weeks each. HDLs were isolated by ultracentrifugation and miRNAs were quantified by RT-qPCR. Variations in HDL-miR-223-3p concentration were negatively correlated with variations in HDL-cholesterol after the iTFA diet (rs = 0.82; P = 0.007), and positively correlated with variations in C-reactive protein concentration after the rTFA diet (rs = 0.75; P = 0.020). Variations in HDL-miR-135a-3p concentration were positively correlated with variations in total triglyceride (TG) concentration following the iTFA diet (rs = -0.82; P = 0.007), and with variations in low-density lipoprotein (LDL)-TG concentration following the rTFA diet (rs = 0.83; P = 0.005), compared to the control diet. However, the consumption of dietary TFAs has no significant unidirectional impact on HDL-carried miR-223-3p and miR-135a-3p concentrations. Our results suggest that the variability in the HDL-carried miRNAs response to TFA intake, by being associated with variations in CVD risk factors, might reflect physiological changes in HDL functions.

Entities:  

Keywords:  Blood miRNA; CVD; HDL; TFA; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27099924      PMCID: PMC4939930          DOI: 10.1080/15592294.2016.1176816

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  63 in total

Review 1.  Exploiting microRNAs for cell engineering and therapy.

Authors:  Tomaž Bratkovič; Gordana Glavan; Borut Strukelj; Marko Zivin; Boris Rogelj
Journal:  Biotechnol Adv       Date:  2012-01-21       Impact factor: 14.227

2.  Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability.

Authors:  Ioanna S Sourvinou; Athina Markou; Evi S Lianidou
Journal:  J Mol Diagn       Date:  2013-08-27       Impact factor: 5.568

3.  Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.

Authors:  S Moorjani; A Dupont; F Labrie; P J Lupien; D Brun; C Gagné; M Giguère; A Bélanger
Journal:  Metabolism       Date:  1987-03       Impact factor: 8.694

4.  Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?

Authors:  Stephen R Master; Daniel J Rader
Journal:  Clin Chem       Date:  2013-03-13       Impact factor: 8.327

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

7.  Natural Rumen-Derived trans Fatty Acids Are Associated with Metabolic Markers of Cardiac Health.

Authors:  Marine S Da Silva; Pierre Julien; Louis Pérusse; Marie-Claude Vohl; Iwona Rudkowska
Journal:  Lipids       Date:  2015-07-26       Impact factor: 1.880

8.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  9 in total

1.  Retracted Article: MicroRNA-135a alleviates lipid accumulation and inflammation of atherosclerosis through targeting lipoprotein lipase.

Authors:  Juan Li; Peng Li; Yanzhuo Zhao; Xiang Ma; Ruili He; Ketai Liang; Erwei Zhang
Journal:  RSC Adv       Date:  2019-09-09       Impact factor: 4.036

2.  GAS5 knockdown suppresses inflammation and oxidative stress induced by oxidized low-density lipoprotein in macrophages by sponging miR-135a.

Authors:  Yunyan Zhang; Xianben Lu; Minjun Yang; Jiaolin Shangguan; Yanping Yin
Journal:  Mol Cell Biochem       Date:  2020-10-31       Impact factor: 3.396

3.  Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR-92a Levels in Humans.

Authors:  Charlotte P J Talbot; Ronald P Mensink; Lotte Smolders; Virginie Bakeroot; Jogchum Plat
Journal:  Mol Nutr Food Res       Date:  2018-06-19       Impact factor: 5.914

4.  The pleiotropic vasoprotective functions of high density lipoproteins (HDL).

Authors:  Guilaine Boyce; Emily Button; Sonja Soo; Cheryl Wellington
Journal:  J Biomed Res       Date:  2017-05-26

Review 5.  MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target.

Authors:  Meng-Wan Zhang; Yun-Jie Shen; Jing Shi; Jian-Guang Yu
Journal:  Front Cardiovasc Med       Date:  2021-01-20

6.  Plasma exosome-derived microRNAs expression profiling and bioinformatics analysis under cross-talk between increased low-density lipoprotein cholesterol level and ATP-sensitive potassium channels variant rs1799858.

Authors:  Cheng Liu; Yanxian Lai; Songsong Ying; Junfang Zhan; Yan Shen
Journal:  J Transl Med       Date:  2020-12-03       Impact factor: 5.531

7.  Elucidation of physico-chemical principles of high-density lipoprotein-small RNA binding interactions.

Authors:  Danielle L Michell; Ryan M Allen; Ashley B Cavnar; Danielle M Contreras; Minzhi Yu; Elizabeth M Semler; Clark Massick; Chase A Raby; Mark Castleberry; Marisol A Ramirez; Wanying Zhu; Linda May-Zhang; Anca Ifrim; John Jeffrey Carr; James G Terry; Anna Schwendeman; Sean S Davies; Quanhu Sheng; MacRae F Linton; Kasey C Vickers
Journal:  J Biol Chem       Date:  2022-04-18       Impact factor: 5.486

Review 8.  Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials.

Authors:  Karla MacDonald-Ramos; Alejandra Martínez-Ibarra; Adriana Monroy; Juan Miranda-Ríos; Marco Cerbón
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

9.  Functional role of microRNA-135a in colitis.

Authors:  Chunyan Lou; Yanyang Li
Journal:  J Inflamm (Lond)       Date:  2018-04-06       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.